Header Logo

Connection

Debra Richardson to Antineoplastic Agents

This is a "connection" page, showing publications Debra Richardson has written about Antineoplastic Agents.
Connection Strength

1.107
  1. The emerging use of antibody-drug conjugates in ovarian cancer. Clin Adv Hematol Oncol. 2023 05; 21(5):244-246.
    View in: PubMed
    Score: 0.572
  2. A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors. Clin Ther. 2024 Mar; 46(3):228-238.
    View in: PubMed
    Score: 0.152
  3. Advances in antibody-drug conjugates for gynecologic malignancies. Curr Opin Obstet Gynecol. 2023 02 01; 35(1):6-14.
    View in: PubMed
    Score: 0.139
  4. Olaparib in the treatment of ovarian cancer. Future Oncol. 2019 Oct; 15(30):3435-3449.
    View in: PubMed
    Score: 0.111
  5. New and Novel Therapies for Gynecologic Cancers. Semin Oncol Nurs. 2019 Apr; 35(2):217-219.
    View in: PubMed
    Score: 0.107
  6. Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment. Am J Clin Oncol. 2018 05; 41(5):447-451.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.